Status
Conditions
Treatments
About
The purpose of this study is to assess the safety and efficacy of hypofractionated stereotactic LINAC radiotherapy with 10 fractions at 6 Gy per fraction at the 80% isodose for the planning target volume (PTV) in patients with uveal melanoma. Patients will be followed-up for 10 years after radiotherapy regarding local tumor control, visual acuity, secondary complications and survival.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
155 participants in 1 patient group
Loading...
Central trial contact
Karin Dieckmann, MD; Martin Zehetmayer, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal